CollPlant Biotechnologies’ (CLGN) Buy Rating Reaffirmed at D. Boral Capital
D. Boral Capital reissued their buy rating on shares of CollPlant Biotechnologies (NASDAQ:CLGN – Free Report) in a research note released on Thursday,Benzinga reports. D. Boral Capital currently has a $14.00 price target on the stock. Separately, HC Wainwright restated a “buy” rating and set a $11.00 target price on shares of CollPlant Biotechnologies in […]
More Stories
ZoomInfo Technologies Inc. (NASDAQ:ZI) Shares Purchased by JPMorgan Chase & Co.
JPMorgan Chase & Co. boosted its holdings in ZoomInfo Technologies Inc. (NASDAQ:ZI – Free Report) by 35.4% during the 4th...
Prudential Financial Inc. Decreases Stake in SpartanNash (NASDAQ:SPTN)
Prudential Financial Inc. lessened its holdings in shares of SpartanNash (NASDAQ:SPTN – Free Report) by 31.4% in the 4th quarter,...
KLP Kapitalforvaltning AS Purchases New Position in TransMedics Group, Inc. (NASDAQ:TMDX)
KLP Kapitalforvaltning AS acquired a new position in TransMedics Group, Inc. (NASDAQ:TMDX – Free Report) in the 4th quarter, Holdings...
KLP Kapitalforvaltning AS Acquires Shares of 4,900 Triumph Financial, Inc. (NASDAQ:TFIN)
KLP Kapitalforvaltning AS acquired a new stake in Triumph Financial, Inc. (NASDAQ:TFIN – Free Report) in the 4th quarter, according...
KLP Kapitalforvaltning AS Makes New Investment in LiveRamp Holdings, Inc. (NYSE:RAMP)
KLP Kapitalforvaltning AS purchased a new position in LiveRamp Holdings, Inc. (NYSE:RAMP – Free Report) during the fourth quarter, Holdings...
Blair William & Co. IL Has $372,000 Stock Position in Haleon plc (NYSE:HLN)
Blair William & Co. IL lessened its holdings in shares of Haleon plc (NYSE:HLN – Free Report) by 3.1% during...